Mirati Therapeutics Inc (was acquisied by Bristol Myers Squibb (NYSE: BMY) on 23/01/2024) (MRTX) Event Aug. 03, 2022, 20:04 UTC 13 1 comments (30% Negative) MIRATI THERAPEUTICS, INC. (MRTX) Reports Q3 2022 Financial Results Comment Full text
Fate Therapeutics Inc (FATE) Event Aug. 03, 2022, 20:03 UTC 13 1 comments (10% Negative) FATE THERAPEUTICS, INC. (FATE) Reports Q3 2022 Financial Results Comment Full text
Personalis Inc (PSNL) Event Aug. 03, 2022, 20:01 UTC 13 1 comments (30% Negative) Personalis, Inc. (PSNL) Reports Q3 2022 Financial Results Comment Full text
Spectrum Pharmaceuticals Inc (was acquised by Assertio Holdings, Inc (NASDAQ:ASRT) on 31/07/2023) (SPPI) Event Aug. 03, 2022, 14:17 UTC 14 1 comments (99% Neutral) SPECTRUM PHARMACEUTICALS INC (SPPI) Provides Business Update Comment Full text
Geron Corporation Inc (GERN) Event Aug. 03, 2022, 13:32 UTC 95 0 comments Geron - Wedbush PacGrow Healthcare Conference 2022 Comment Full text
Landos Biopharma Inc (was acquired by AbbVie Inc. (NYSE: ABBV) on 25/03/2024) (LABP) Event Aug. 03, 2022, 12:30 UTC 14 1 comments (90% Positive) Landos Biopharma, Inc. (LABP) Announces Enrollment Update for milestone Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
Morphic Therapeutic (MORF) Event Aug. 03, 2022, 12:05 UTC 12 1 comments (30% Negative) Morphic Holding, Inc. (MORF) Reports Q3 2022 Financial Results Comment Full text
Pacira BioSciences Inc (PCRX) Event Aug. 03, 2022, 12:02 UTC 12 1 comments (10% Negative) PACIRA BIOSCIENCES, INC. (PCRX) Reports Q3 2022 Financial Results Comment Full text
Poseida Therapeutics (PSTX) Event Aug. 03, 2022, 11:36 UTC 12 1 comments (19% Negative) Poseida Therapeutics, Inc. (PSTX) Announces Delay in million Trials for multiple myeloma Due to Regulatory Process, Manufacturing Considerations, Efficacy Assessment Comment Full text
Kiniksa Pharmaceuticals (KNSA) Event Aug. 03, 2022, 11:35 UTC 12 1 comments (10% Negative) Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q3 2022 Financial Results Comment Full text